How old is patient? |
Pregnancy of Slimfast in details

Slimfast has been assigned to pregnancy category X by the FDA. High-dose animal studies have failed to reveal evidence of embryotoxicity or teratogenicity. There are no controlled data in human pregnancy. Since weight loss offers no potential benefit to a pregnant woman and may result in fetal harm, Slimfast is contraindicated during pregnancy. If Slimfast is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard of maternal weight loss to the fetus.
See references
Slimfast breastfeeding

There are no data on the excretion of Slimfast into human milk. The manufacturer advices that Slimfast should not be taken by nursing women.
See references
References for pregnancy information
- "Product Information. Xenical (Slimfast)." Roche Laboratories, Nutley, NJ.
References for breastfeeding information
- "Product Information. Xenical (Slimfast)." Roche Laboratories, Nutley, NJ.
References
- DailyMed. "ORLISTAT: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
- PubMed Health. "Orlistat (By mouth): This section provide the link out information of drugs collectetd in PubMed Health. ". http://www.ncbi.nlm.nih.gov/pubmedhe... (accessed September 17, 2018).
- Human Metabolome Database (HMDB). "Orlistat: The Human Metabolome Database (HMDB) is a freely available electronic database containing detailed information about small molecule metabolites found in the human body.". http://www.hmdb.ca/metabolites/HMDB0... (accessed September 17, 2018).
Reviews
Consumer reviews
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology